Invesco DWA Healthcare Momentum ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of at least 30 securities of companies in the healthcare sector that have powerful relative strength or "momentum" characteristics.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 6M SHOWN · NET +$113M OVER THIS RANGE
Money keeps arriving — +$32M of net buying over the past month, about 12.0% of the fund's asset base, while the price has returned +27.9% so far this year. At 0.60% a year it is not the cheapest way in — IBRN runs the same ground at 0.47%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS TODAY’S MOVE · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES | 5.21% | $209.46 | -1.1% | ||
| 2 | ROIVROIVANT SCIENCES | 5.02% | $36.30 | -1.5% | ||
| 3 | GHGUARDANT HEALTH | 4.81% | $170.69 | +1.7% | ||
| 4 | MRNAMODERNA | 4.31% | $145.13 | +8.9% | ||
| 5 | BTSGBRIGHTSPRING HEALTH SERVICES INC | 3.75% | $58.87 | -1.1% | ||
| 6 | AXSMAXSOME THERAPEUTICS | 3.68% | $207.77 | -0.1% | ||
| 7 | TXG10X GENOMICS | 2.87% | $65.12 | +2.0% | ||
| 8 | ORKAOruka Therapeutics | 2.78% | $107.96 | +3.0% | ||
| 9 | ERASERASCA | 2.59% | $17.63 | +3.2% | ||
| 10 | REPLREPLIMUNE GROUP | 2.26% | $14.77 | +5.1% | ||
| 11 | TVTXTRAVERE THERAPEUTICS | 2.32% | $65.71 | +1.9% | ||
| 12 | TWSTTWIST BIOSCIENCE | 2.21% | $145.59 | +6.8% | ||
| 13 | AXGNAXOGEN | 2.12% | $50.40 | +8.5% | ||
| 14 | LQDALIQUIDIA | 2.38% | $68.62 | -3.4% | ||
| 15 | RLAYRELAY THERAPEUTICS | 2.20% | $19.44 | -1.3% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 60| 1 week | +3.5% |
| 1 month | +7.5% |
| 3 months | +23.0% |
| 6 months | +27.7% |
| YTD | +27.9% |
| 1 year | +57.9% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$1M |
| 1 month | +$32M |
| 3 months | +$122M |
| YTD | +$120M |
| 1 year | +$118M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 5.2% of the book; the top ten carry 37%. Spread across 56+ names, it behaves like roughly 40 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| MRNA MODERNA | $178M | $164M |
| HIMS HIMS & HERS HEALTH | $13M | $10M |
| HUM HUMANA | $6M | $4M |
| KRYS KRYSTAL BIOTECH | $4M | $2M |
| RVMD REVOLUTION MEDICINES | $2M | $3M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat PTH on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| IUSG iShares Core S&P U.S. Growth ETF | 0.04% | $33.8B | +$668M | -56bp on fee · 126× the assets · +$668M in over the month | Head-to-head |
| IUSV iShares Core S&P U.S. Value ETF | 0.04% | $28.1B | +$103M | -56bp on fee · 104× the assets · +$103M in over the month | Head-to-head |
| ILCG iShares Morningstar Growth ETF | 0.04% | $3.3B | +$7M | -56bp on fee · 12× the assets · +$7M in over the month | Head-to-head |
| VUG Vanguard Growth Index Fund | 0.04% | $135.5B | — | -56bp on fee · 503× the assets | Head-to-head |
| VTV Vanguard Value Index Fund | 0.04% | $125.5B | — | -56bp on fee · 466× the assets | Head-to-head |